1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Trastuzumab emtansine
Trade Name:
Kadcyla
Manufacturer/Distributor:
Hoffman-La Roche
www.rochecanada.com 1-888-762-4388
Classification:
Antineoplastic agent
ATC Class:
L01XC - other antineoplastic agents
Status:
active
Notice of Compliance (yyyy/mm/dd):
2013/09/11
Date Marketed in Canada (yyyy/mm/dd):
2013/09/27
Presentation:
Powder for injection: 20 mg/mL. DIN: 024121365
Comments:
Kadcyla™ is trastuzumab emtansine. It is a HER2-targeted antibody-drug conjugate for treatment of patients with HER2-positive, metastatic breast cancer who have received both prior treatment with Herceptin™ (trastuzumab) and a taxane, separately or in combination. Kadcyla™ is a different product from Herceptin™.
Back to:
Drug Product Listings 
